Towards ECCMID 2023: #Infection control and prevention

(55)

Towards ECCMID 2023: #Zoonoses, vector-borne and one health

(1:7)

Towards ECCMID 2023: #Virulence and pathogenesis

(1:25)

Towards ECCMID 2023: #Travel medicine and migrant health

(1:52)

Towards ECCMID 2023 - Shaping the programme

(2:17)

Towards ECCMID 2023: #Epidemiology of infection

(1:25)

Towards ECCMID 2023: The new hashtag concept

(2:15)

Towards ECCMID 2023: #Mycobacteria

(1:8)

ESCMID Global TV 2024: An interview with the Keynote Speaker, Mihai Netea

(14:23)

ESCMID Global 2024 TV: An interview with the Keynote Speaker, Mervyn Singer

(14:41)

CMI Communications: An interview with Editor-in-Chief Angela Huttner, MD

(14:56)

Anu Kantele | Infektiosairaudet, Superbakteerit ja Rokotteet #24 (AUDIO)

(43:55)

[CES 2023] HD Hyundai press conference opening remarks

(7:56)

Which guidelines and online resources you may use to prepare for FRCPath Microbiology?

(14:8)

Medical Microbiology FRCPath Part 2 – What I Wish I’d Known

(23:27)

Insight into a Microbiology Lab

(5:53)

ESCMID/ASM Conference 2024: Jack Stanley

(13:55)

Towards ECCMID 2023: #Antimicrobial Stewardship (AMS)

(1:43)

Towards ECCMID 2023: #Basic and translational research

(1:6)

Towards ECCMID 2023: #Antimicrobial resistance (AMR)

(2:13)

Towards ECCMID 2023: #Critical care

(2:59)

Towards ECCMID 2023: #Vaccinology

(1:44)

Towards ECCMID 2023: Selective Pressure, the new ESCMID quiz show

(1:21)

Towards ECCMID 2023: #Healthcare associated infections (HCAI)

(3:57)

Towards ECCMID 2023: #Clinical trials

(2:)

Towards ECCMID 2023: #Public health and surveillance

(2:56)

Towards ECCMID 2023: #HIV/AIDS, hepatitis and bloodborne infections

(2:3)

Towards ECCMID 2023: #Fungi and clinical mycology

(1:58)